Cosmo Bio Company,Limited (3386.T)

JPY 1129.0

(0.62%)

Gross Profit Summary of Cosmo Bio Company,Limited

  • Cosmo Bio Company,Limited's latest annual gross profit in 2023 was 3.25 Billion JPY , down -5.55% from previous year.
  • Cosmo Bio Company,Limited's latest quarterly gross profit in 2024 Q2 was 726 Million JPY , down -26.44% from previous quarter.
  • Cosmo Bio Company,Limited reported a annual gross profit of 3.44 Billion JPY in annual gross profit 2022, down -5.96% from previous year.
  • Cosmo Bio Company,Limited reported a annual gross profit of 3.65 Billion JPY in annual gross profit 2021, up 16.09% from previous year.
  • Cosmo Bio Company,Limited reported a quarterly gross profit of 726 Million JPY for 2024 Q2, down -26.44% from previous quarter.
  • Cosmo Bio Company,Limited reported a quarterly gross profit of 1.03 Billion JPY for 2023 Q1, up 22.24% from previous quarter.

Annual Gross Profit Chart of Cosmo Bio Company,Limited (2023 - 2019)

Historical Annual Gross Profit of Cosmo Bio Company,Limited (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 3.25 Billion JPY -5.55%
2022 3.44 Billion JPY -5.96%
2021 3.65 Billion JPY 16.09%
2020 3.15 Billion JPY 9.44%
2019 2.88 Billion JPY 0.0%

Peer Gross Profit Comparison of Cosmo Bio Company,Limited

Name Gross Profit Gross Profit Difference
Shin Nippon Biomedical Laboratories, Ltd. 14.28 Billion JPY 77.245%
DNA Chip Research Inc. 66.35 Million JPY -4798.045%
H.U. Group Holdings, Inc. 63.23 Billion JPY 94.86%
FALCO HOLDINGS Co., Ltd. 12.71 Billion JPY 74.442%
BML, Inc. 45.62 Billion JPY 92.877%
Human Metabolome Technologies, Inc. 869.33 Million JPY -273.85%
Precision System Science Co., Ltd. 950.37 Million JPY -241.97%